Clinical trial

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

NCT01847001

Study summary

ClinicalTrials.gov

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

12 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Propranolol Normalized identity: propranolol View linked drug · Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention DOT imaging Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Paclitaxel Normalized identity: paclitaxel View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Nab-paclitaxel Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Trastuzumab Normalized identity: trastuzumab View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Pertuzumab Normalized identity: pertuzumab View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Doxorubicin Normalized identity: doxorubicin View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Cyclophosphamide Normalized identity: cyclophosphamide View linked drug · Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Surgery Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Premedication Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Anti-nausea therapy Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Pegfilgrastim Normalized identity: pegfilgrastim View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-10-01

PhasePHASE2

Conditions

Locally Advanced Malignant Neoplasmunresolved

Breast Cancerverified · MONDO: breast cancer

Interventions

PropranololDRUG · verified · RxNorm: propranolol

DOT imagingOTHER

PaclitaxelDRUG · verified · RxNorm: paclitaxel

Nab-paclitaxelDRUG

TrastuzumabDRUG · verified · RxNorm: trastuzumab

PertuzumabDRUG · verified · RxNorm: pertuzumab

DoxorubicinDRUG · verified · RxNorm: doxorubicin

CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

SurgeryPROCEDURE

PremedicationDRUG

Anti-nausea therapyDRUG

PegfilgrastimDRUG · verified · RxNorm: pegfilgrastim

Sponsors & collaborators

Columbia Universitylead sponsor

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01847001 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.